LINK MEDICINE CORP has a total of 39 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Israel. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CAVALLA DAVID, LILLY ICOS LLC and TIANJIN TIANSHILI PHARMACEUTIC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Israel | 5 | |
#4 | Canada | 4 | |
#5 | United States | 4 | |
#6 | Brazil | 3 | |
#7 | Mexico | 3 | |
#8 | Australia | 2 | |
#9 | China | 2 | |
#10 | South Africa | 2 | |
#11 | New Zealand | 1 | |
#12 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Duggan Mark E | 14 |
#2 | Justman Craig J | 13 |
#3 | Liu Zhihua | 10 |
#4 | Lansbury Peter T | 7 |
#5 | Lansbury Peter T Jr | 7 |
#6 | Williams Peter J | 5 |
#7 | Grammatopoulos Tom N | 5 |
#8 | Justman Craig | 5 |
#9 | Lynch Berkley | 5 |
#10 | Grammatopoulos Tom | 5 |
Publication | Filing date | Title |
---|---|---|
MX2011013016A | Aminopyrrolidinone derivatives and uses thereof. | |
US2010331363A1 | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor | |
US2011060005A1 | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor | |
CN102369202A | Azaquinolinone derivatives and uses thereof | |
BRPI0921113A2 | treatment of proteinopathies using a farnesyl transferase inhibitor. | |
US2010292292A1 | Treatment of Neurodegenerative Diseases Using Indatraline Analogs | |
WO2008137692A1 | Treatment of synucleinopathies | |
EP2155197A2 | Treatment of lysosomal storage diseases | |
WO2007092285A2 | Treatment of synucleinopathies | |
AU2006331542A1 | Treatment of synucleinopathies |